Article Text

Download PDFPDF

P01 Audit of labinic probiotics on the neonatal unit
  1. Sian Gaze1,
  2. Umair Ahmad Fuad2
  1. 1Evelina London’s Hospital
  2. 2King’s College London University


Background Our neonatal unit was reviewed by the GIRFT team (Getting It Right First Time) in 2019. One of the recommendations from their report was the introduction of probiotics, to help reduce the incidence of necrotising enterocolitis (NEC). NEC is a devastating illness, which contributes to significant morbidity and mortality in the neonatal population. A variety of probiotics were assessed for safety and clinical efficacy.1–3 Labinic was chosen as it contained an optimum combination of probiotic organisms to minimise the risk of NEC developing. In January 2021, Labinic was added to the hospital formulary and Trust guidelines for babies aged < 32 weeks and/or weighing <1.5kg at birth.4

Aims To assess whether premature babies on the neonatal unit were receiving Labinic probiotic drops, as per recently published Trust guidelines.

Objectives To identify whether babies were prescribed and administered Labinic at the correct dose, frequency and timing according to the guidance.

Methods A report was run via Badgernet and Medchart to identify patients eligible for inclusion in the study, from January 2021 to October 2021.

Inclusion Criteria

  1. Patient was prescribed Labinic

  2. Patient was born at our hospital

  3. Patient was born <32 weeks or was born aged 32–36 weeks and weighed <1.5kg

Inclusion CriteriaBadgernet was used to collect patient-related data:

  • time of the patient’s first feed/colostrum

  • birth weight

  • time of delivery

  • location of birth

Medchart was used to gather data about Labinic prescribing and administration. Patient information was held in a password protected Excel spreadsheet to maintain confidentiality. A pilot data collection form was trialled for 1 week, then adapted. Ethics approval was not required for this study. The audit was registered with the Trust.

Results Data was collected for 76 patients who were prescribed and administered Labinic on the neonatal intensive care unit from January 2021 to October 2021. The mean gestational age of the patients was 28 weeks (23–36 weeks) and the mean weight was 990 grams (500–2200 grams). 76/76 (100%) babies eligible to receive Labinic were prescribed and administered the probiotic. 76/76 (100%) patients were prescribed the correct dose according to their age/weight. The recommendations are that Labinic should be administered either with the first feed or within 12 hours of birth, whichever comes first. Only 17/76 (22%) of infants received Labinic within the first 12 hours.

Conclusions The introduction of Labinic probiotics has been widely accepted and well implemented on the neonatal unit. Within 2 years of the GIRFT report’s recommendations, the unit has gone from having 0% of eligible patients receiving probiotics to 100% of babies receiving them. Unfortunately, the number of patients included in the study was too low to assess the overall impact on NEC rates. Further education and training will be provided to nursing staff about the importance of administering the first dose of Labinic within the first 12 hours of life. The Trust guidance and electronic prescribing tools will be updated and re-circulated, to highlight that the first dose should be administered within 12 hours, and not delayed until after colostrum or expressed breast milk is available. The audit will be repeated in future to check good practice is maintained and timing of first dose is improved.


  1. Morelli L, Capurso L. FAO/WHO guidelines on probiotics. Journal of Clinical Gastroenterology 2012;46:S1-S2.

  2. Allin B, Long A, Gupta A, Knight M, Lakhoo K. A UK wide cohort study describing management and outcomes for infants with surgical necrotising enterocolitis. Scientific Reports 2017;7:41149. Available from:

  3. Jin Y, Duan Y, Deng X, Lin J. Prevention of necrotizing enterocolitis in premature infants – an updated review. World Journal of Clinical Pediatrics [Internet] 2019 [cited 20 December 2021];8(2):23–32. Available from:

  4. Probiotics Guidance, Evelina London Children’s Hospital, Guy’s & St Thomas’ NHS Foundation Trust.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.